Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: Overview, diagnostic considerations, and infectious complications

Pediatric Blood and Cancer

Volumn 49, Issue 2, 2007, Pages 117-126

  Collaco, J Michael ^a   Gower, W Adam ^a   Mogayzel Jr , Peter J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bone marrow transplant (BMT); Hematopoietic stem cell transplant (HSCT); Infection; Pediatric; Pneumonia; Pneumonitis; Pulmonary complications

Indexed keywords

ACICLOVIR; AMPHOTERICIN; AMPHOTERICIN B; CASPOFUNGIN; CIDOFOVIR; CORTICOSTEROID; FLUCONAZOLE; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; PALIVIZUMAB; RIBAVIRIN; RIFAMPICIN; VORICONAZOLE;

ADENOVIRUS; ASPERGILLUS FUMIGATUS; BACTERIAL PNEUMONIA; BRONCHOSCOPY; BRONCHUS BIOPSY; CANDIDIASIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; INCIDENCE; INFLUENZA VIRUS; LUNG DISEASE; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NEUTROPENIA; OPEN LUNG BIOPSY; PARAINFLUENZA VIRUS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; TRANSBRONCHIAL BIOPSY; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; LUNG DISEASES; LUNG DISEASES, FUNGAL; NEOPLASMS; NEUTROPENIA; PNEUMONIA; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION CONDITIONING;

EID: 34447290025     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21061     Document Type: Review

References (156)

1. Eikenberry M, Bartakova H, Defor T, et al. Natural history of pulmonary complications in children after bone marrow transplantation. Biol Blood Marrow Transplant 2005;11:56-64.
2. Griese M, Rampf U, Hofmann D, et al. Pulmonary complications after bone marrow transplantation in children: Twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30:393-401.
3. Mori M, Galvin JR, Barloon TJ, et al. Fungal pulmonary infections after bone marrow transplantation: Evaluation with radiography and CT. Radiology 1991;178:721-726.
4. Barloon TJ, Galvin JR, Mori M, et al. High-resolution ultrafast chest CT in the clinical management of febrile bone marrow transplant patients with normal or nonspecific chest roentgenograms. Chest 1991;99:928-933.
5. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography. J Clin Oncol 1999;17:796-805.
6. Graham NJ, Muller NL, Miller RR, et al. Intrathoracic complications following allogeneic bone marrow transplantation: CT findings. Radiology 1991;181:153-156.
7. Schueller G, Matzek W, Kalhs P, et al. Pulmonary infections in the late period after allogeneic bone marrow transplantation: Chest radiography versus computed tomography. Eur J Radiol 2005; 53:489-494.
8. McCubbin MM, Trigg ME, Hendricker CM, et al. Bronchoscopy with bronchoalveolar lavage in the evaluation of pulmonary complications of bone marrow transplantation in children. Pediatr Pulmonol 1992;12:43-47.
9. Lanino E, Sacco O, Kotitsa Z, et al. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary infiltrates after BMT in children. Bone Marrow Transplant 1996;18:117-120.
10. Ben Ari J, Yaniv I, Nahum E, et al. Yield of bronchoalveolar lavage in ventilated and non-ventilated children after bone marrow transplantation. Bone Marrow Transplant 2001;27:191-194.
11. Bojko T, Notterman DA, Greenwald BM, et al. Acute hypoxemic respiratory failure in children following bone marrow transplantation: An outcome and pathologic study. Crit Care Med 1995; 23:755-759.
12. Snyder CL, Ramsay NK, McGlave PB, et al. Diagnostic open-lung biopsy after bone marrow transplantation. J Pediatr Surg 1990; 25:871-876.
13. Patel NR, Lee PS, Kim JH, et al. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest 2005;127: 1388-1396.
14. Shorter NA, Ross AJ III, August C, et al. The usefulness of open-lung biopsy in the pediatric bone marrow transplant population. J Pediatr Surg 1988;23:533-537.
15. Hayes-Jordan A, Benaim E, Richardson S, et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002; 37:446-452.
16. Dunn JC, West KW, Rescorla FJ, et al. The utility of lung biopsy in recipients of stem cell transplantation. J Pediatr Surg 2001; 36:1302-1303.
17. Armenian SH, La Via WV, Siegel SE, et al. Evaluation of persistent pulmonary infiltrates in pediatric oncology patients. Pediatr Blood Cancer 2006.
18. Lossos IS, Breuer R, Or R, et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995;60:672-678.
19. Sullivan KM, Dykewicz CA, Longworth DL, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology (Am Soc Hematol Educ Program) 2001; 392-421.
20. Dettenkofer M, Ebner W, Bertz H, et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 2003;31:795-801.
21. Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study. Biol Blood Marrow Transplant 2002;8:512-520.
22. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22-48.
23. Huaringa AJ, Leyva FJ, Signes-Costa J, et al. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 2000;25: 975-979.
24. Laws HJ, Kobbe G, Dilloo D, et al. Surveillance of nosocomial infections in paediatric recipients of bone marrow or peripheral blood stem cell transplantation during neutropenia, compared with adult recipients. J Hosp Infect 2006;62:80-88.
25. Wingard JR, Anaissie E. Infectious complications after hematopoietic cell transplantation. In: Mehta P, editor. Pediatric stem cell transplantation. Sudbury, MA: Jones and Bartlett Publishers; 2004. pp 389-400.
26. Oren I, Zuckerman T, Avivi I, et al. Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: Evaluation, treatment and control. Bone Marrow Transplant 2002;30:175-179.
27. Harrington RD, Woolfrey AE, Bowden R, et al. Legionellosis in a bone marrow transplant center. Bone Marrow Transplant 1996;18: 361-368.
28. Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002;100:4358-4366.
29. Benjamin DK Jr. Miller WC, Bayliff S, et al. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002;21:227-234.
30. Hovi L, Saarinen-Pihkala UM, Vettenranta K, et al. Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years. Bone Marrow Transplant 2000;26:999-1004.
31. Kojima R, Kami M, Nannya Y, et al. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant 2004;10:645-652.
32. Fukuda T, Boeckh M, Guthrie KA, et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004;10:494-503.
33. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003;102:827-833.
34. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19:801-808.
35. Alberti C, Bouakline A, Ribaud P, et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect 2001;48: 198-206.
36. Jantunen E, Piilonen A, Volin L, et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000;25:867-871.
37. Meyer S, Reinhard H, Gottschling S, et al. Pulmonary dysfunction in pediatric oncology patients. Pediatr Hematol Oncol 2004;21: 175-195.
38. Barnes C, Berkowitz R, Curtis N, et al. Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation. Int J Pediatr Otorhinolaryngol 2001;59: 59-62.
39. Kapelushnik J, Springer C, Naparstek E, et al. Tracheoesophageal fistula induced by aspergillus infection following bone marrow transplantation. Pediatr Pulmonol 1994;17:202-204.
40. Takatsuka H, Wakae T, Mori A, et al. Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: A case report. Hematology 2002;7:169-172.
41. Thomas KE, Owens CM, Veys PA, et al. The radiological spectrum of invasive aspergillosis in children: A 10-year review. Pediatr Radiol 2003;33:453-460.
42. Roychowdhury M, Pambuccian SE, Asian DL, et al. Pulmonary complications after bone marrow transplantation: An autopsy study from a large transplantation center. Arch Pathol Lab Med 2005;129:366-371.
43. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000;355:423-424.
44. Simoneau E, Kelly M, Labbe AC, et al. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant 2005;35:303-306.
45. Bialek R, Moshous D, Casanova JL, et al. Aspergillus antigen and PCR assays in bone marrow transplanted children. Eur J Med Res 2002;7:177-180.
46. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100:171-178.
47. Hoffer FA, Gow K, Flynn PM, et al. Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 2001;31:144-152.
48. Wenzel R, Del Favero A, Kibbler C, et al. Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. J Antimicrob Chemother 2005;55:352-361.
49. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.
50. Patterson TF, Boucher HW, Herbrecht R, et al. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome. Clin Infect Dis 2005;41:1448-1452.
51. Pancham S, Hemmaway C, New H, et al. Caspofungin for invasive fungal infections: Combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pediatr Transplant 2005;9:254-257.
52. Schuster F, Moelter C, Schmid I, et al. Successful antifungal combination therapy with voriconazole and caspofungin. Pediatr Blood Cancer 2005;44:682-685.
53. Kontoyiannis DP, Boktour M, Hanna H, et al. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 2005;103:2334-2337.
54. Ito JI, Chandrasekar PH, Hooshmand-Rad R. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). Bone Marrow Transplant 2005;36:873-877.
55. Gow KW, Hayes-Jordan AA, Billups CA, et al. Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes. J Pediatr Surg 2003;38:1354-1360.
56. Afessa B, Peters SG. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 2006;27:297-309.
57. Chen CS, Boeckh M, Seidel K, et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:515-522.
58. Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest 1996;109:1066-1077.
59. Wah TM, Moss HA, Robertson RJ, et al. Pulmonary complications following bone marrow transplantation. Br J Radiol 2003;76:373-379.
60. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis 2005;191:1350-1360.
61. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004;350:950-952.
62. Siwek GT, Dodgson KJ, Magalhaes-Silverman M, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004;39: 584-587.
63. Imhof A, Balajee SA, Fredricks DN, et al. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004;39:743-746.
64. Kontoyiannis DP, Wessel VC, Bodey GP, et al. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000;30: 851-856.
65. Kauffman CA. Zygomycosis: Reemergence of an old pathogen. Clin Infect Dis 2004;39:588-590.
66. Maertens J, Demuynck H, Verbeken EK, et al. Mucormycosis in allogeneic bone marrow transplant recipients: Report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999;24:307-312.
67. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005;41:634-653.
68. Chamilos G, Marom EM, Lewis RE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005;41:60-66.
69. Leleu X, Sendid B, Fruit J, et al. Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;24:417-420.
70. Jules-Elysee K, Stover DE, Yahalom J, et al. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 1992;146:485-491.
71. Ljungman P, Ellis MN, Hackman RC, et al. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation. J Infect Dis 1990;162:244-248.
72. Kitabayashi A, Hirokawa M, Horiuchi T, et al. Late-onset herpes simplex virus-associated interstitial pneumonia after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25: 225-226.
73. Gasparetto EL, Escuissato DL, Inoue C, et al. Herpes simplex virus type 2 pneumonia after bone marrow transplantation - High-resolution CT findings in 3 patients. J Thorac Imaging 2005; 20:71-73.
74. Miyamoto T, Gondo H, Miyoshi Y, et al. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1998;100:348-350.
75. Ramsey PG, Fife KH, Hackman RC, et al. Herpes simplex virus pneumonia: Clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 1982;97:813-820.
76. Abdallah A, Rowland KE, Schepetiuk SK, et al. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: Effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant 2003;32: 195-203.
77. McCarthy AJ, Kingman HM, Kelly C, et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999;24:1315-1322.
78. Anaissie EJ, Mahfouz TH, Asian T, et al. The natural history of respiratory syncytial virus infection in cancer and transplant patients: Implications for management. Blood 2004;103:1611-1617.
79. DeVincenzo JP, Hirsch RL, Fuentes RJ, et al. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - A compassionate use experience. Bone Marrow Transplant 2000;25:161-165.
80. Khushalani NI, Bakri FG, Wentling D, et al. Respiratory syncytial virus infection in the late bone marrow transplant period: Report of three cases and review. Bone Marrow Transplant 2001;27: 1071-1073.
81. Raboni SM, Nogueira MB, Tsuchiya LR, et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003;76:142-146.
82. Escuissato DL, Gasparetto EL, Marchiori E, et al. Pulmonary infections after bone marrow transplantation: High-resolution CT findings in 111 patients. AJR Am J Roentgenol 2005;185:608-615.
83. El Saleeby CM, Suzich J, Conley ME, et al. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation. Clin Infect Dis 2004;39:e17-e20.
84. Ghosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000;25:751-755.
85. Banna GL, Aversa SM, Cattelan AM, et al. Respiratory syncytial virus-related pneumonia after stem cell transplantation successfully treated with palivizumab and steroid therapy. Scand J Infect Dis 2004;36:155-157.
86. Schleuning M, Buxbaum-Conradi H, Jager G, et al. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J 2004;5:135-144.
87. Adams R, Christenson J, Petersen F, Beatty P. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV Bone Marrow Transplant 1999;24:661-664.
88. Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995;16:393-399.
89. Boeckh M, Berrey MM, Bowden RA, et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 2001;184:350-354.
90. Johny AA, Clark A, Price N, et al. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation. Bone Marrow Transplant 2002;29:113-115.
91. Nichols WG, Guthrie KA, Corey L, et al. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004;39:1300-1306.
92. Lewis VA, Champlin R, Englund J, et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 1996;23:1033-1037.
93. Nichols WG, Corey L, Gooley T, et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: Risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001;98:573-578.
94. Machado CM, Boas LS, Mendes AV, et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004;34:111-114.
95. Hentrich M, Oruzio D, Jager G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005;128:66-72.
96. Buchbinder S, Elmaagacli AH, Schaefer UW, et al. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;26:639-644.
97. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991;78:1381-1384.
98. Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993;329:156-161.
99. Kadakia MP, Rybka WB, Stewart JA, et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996;87:5341-5354.
100. Cone RW, Huang ML, Corey L, et al. Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations. J Infect Dis 1999;179:311-318.
101. Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002;29:595-598.
102. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000;26:1333-1338.
103. Howard DS, Phillips GL II, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 1999;29:1494-1501.
104. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169:775-781.
105. Hale GA, Heslop HE, Krance RA, et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999;23:277-282.
106. Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005; 130:595-603.
107. Runde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): Report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001;28:51-57.
108. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001;32:871-876.
109. Walls T, Shankar AG, Shingadia D. Adenovirus: An increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003;3:79-86.
110. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: A survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003;31:481-486.
111. Echavarria M, Forman M, van Tol MJ, et al. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 2001;358:384-385.
112. Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 2002; 110.
113. Jurado CM, Hernandez MF, Navarro Mari JM, et al. Adenovirus pneumonitis successfully treated with intravenous ribavirin. Haematologica 1998;83:1128-1129.
114. Bordigoni P, Carret AS, Venard V, et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2001;32:1290-1297.
115. Ribaud P, Scieux C, Freymuth F, et al. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis 1999;28:690-691.
116. Ison MG, Hayden FG, Kaiser L, et al. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003;36:1139-1143.
117. Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: The Christie hospital experience. Bone Marrow Transplant 2003; 32:73-77.
118. Ison MG, Fishman JA. Cytomegalovirus pneumonia in transplant recipients. Clin Chest Med 2005;26:691-705, viii.
119. Reusser P. Cytomegalovirus infection and disease after bone marrow transplantation: epidemiology, prevention, and treatment. Bone Marrow Transplant 1991;7:52-56.
120. Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004;103:2003-2008.
121. Castagnola E, Cappelli B, Erba D, et al. Cytomegalovirus infection after bone marrow transplantation in children. Hum Immunol 2004;65:416-422.
122. Konoplev S, Champlin RE, Giralt S, et al. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients. Bone Marrow Transplant 2001;27:877-881.
123. Pumannova M, Roubalova K, Vitek A, et al. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation. Diagn Microbiol Infect Dis 2006;54:115-120.
124. Hernando S, Folgueira L, Lumbreras C, et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc 2005;37:4094-4096.
125. Nomura F, Shimokata K, Sakai S, et al. Cytomegalovirus pneumonitis occurring after allogeneic bone marrow transplantation: A study of 106 recipients. Jpn J Med 1990;29:595-602.
126. Slavin MA, Gooley TA, Bowden RA. Prediction of cytomegalovirus pneumonia after marrow transplantation from cellular characteristics and cytomegalovirus culture of bronchoalveolar lavage fluid. Transplantation 1994;58:915-919.
127. Machado CM, Dulley FL, Boas LS, et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment of preemptive ganciclovir therapy. Bone Marrow Transplant 2000;26: 413-417.
128. Einsele H, Reusser P, Bornhauser M, et al. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Blood 2006;107:3002-3008.
129. Cesaro S, Zhou X, Manzardo C, et al. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. J Clin Virol 2005;34:129-132.
130. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006;144:344-349.
131. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 2005;192:1061-1065.
132. Cane PA, van den Hoogen BG, Chakrabarti S, et al. Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003;31:309-310.
133. De Castro N, Neuville S, Sarfati C, et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: A 6-year retrospective study. Bone Marrow Transplant 2005;36:879-883.
134. Pagano L, Fianchi L, Mele L, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. Br J Haematol 2002;117:379-386.
135. Tuan IZ, Dennison D, Weisdorf DJ. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992;10:267-272.
136. Annaloro C, Della VA, Usardi P, et al. Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation. Eur J Clin Microbiol Infect Dis 2005; 1-3.
137. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood 2003;101:407-414.
138. Krause H, Hebart H, Jahn G, et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant 1997;19:1111-1116.
139. Machado CM, Menezes RX, Macedo MC, et al. Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT. Bone Marrow Transplant 2001;28:1053-1059.
140. Nakayama H, Okamura J, Ohga S, et al. Herpes zoster in children with bone marrow transplantation: Report from a single institution. Acta Paediatr Jpn 1995;37:302-307.
141. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr 1996;128:353-356.
142. Wacker P, Hartmann O, Benhamou E, et al. Varicella-Zoster virus-infections after autologous bone-marrow transplantation in children. Bone Marrow Transplant 1989;4:191-194.
143. Han CS, Miller W, Haake R, et al. Varicella tester infection after bone-marrow transplantation - Incidence, risk-factors and complications. Bone Marrow Transplantation 1994;13:277-283.
144. Tzeng CH, Liu JH, Fan S, et al. Varicella-Zoster virus-infection after allogeneic or autologous hematopoietic stem-cell transplantation. J Formos Med Assoc 1995;94:313-317.
145. Arvin AM. Varicella-Zoster virus infections. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoetic cell transplantation. Malden, MA: Blackwell Science,Inc; 1999. pp 591-606.
146. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: Comparison of incidence in related and unrelated donor transplant recipients. Blood 1995;86:3979-3986.
147. Wingard JR. Bacterial infections. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoetic cell transplantation. Malden, MA: Blackwell Science, Inc.; 1999. pp 537-549.
148. Ip MS, Yuen KY, Woo PC, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998;158:1173-1177.
149. Budak-Alpdogan T, Tangun Y, Kalayoglu-Besisik S, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000;6:370-374.
150. Nagasawa M, Maeda H, Okawa H, et al. Pulmonary miliary tuberculosis and T-cell abnormalities in a severe combined immunodeficient patient reconstituted with haploidentical bone-marrow transplantation. Int J Hematol 1994;59:303-309.
151. Chen CC, Huang LM, Chang YL, et al. Acute respiratory distress syndrome due to tuberculosis in a child after allogeneic bone marrow transplantation for acute lymphoblastic leukemia. J Formos Med Assoc 1999;98:701-704.
152. Miale T, Mody N, Dick B, et al. Difficulty in establishing diagnosis from lung biopsies and bronchial washing analysis in children with leukemia following bone marrow transplantation. Cancer Detect Prev Suppl 1987;1:165-172.
153. Navari RM, Sullivan KM, Springmeyer SC, et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983;36: 509-513.
154. Yuen KY, Woo PCY. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002;20:51-62.
155. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: A 20 year retrospective review. Bone Marrow Transplant 1997;19:467-470.
156. Ozkaynak MF, Lenarsky C, Kohn D, et al. Mycobacterium-avium- intracellulare infections after allogeneic bone-marrow transplantation in children. Am J Pediatr Hematol Oncol 1990;12:220-224.